I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Evaluación económica de la inclusión en el calendario vacun..:
Epstein, David Mark
;
Ruiz Montero, Rafael
;
Espín Balbino, Jaime
Ruiz-Montero, R., Epstein, D., Herrador, B. G., & Balbino, J. E. (2020). Evaluación económica de la inclusión en el calendario vacunal de 4CMenB (Bexsero®) en España. Gaceta Sanitaria, 34(4), 318-325. [https://doi.org/10.1016/j.gaceta.2019.08.007]. , 2019
Link:
http://hdl.handle.net/10481/63280
RT Journal T1
Evaluación económica de la inclusión en el calendario vacunal de 4CMenB (Bexsero®) en Espana ; Economic evaluation of the introduction of 4CMenB (Bexsero®) in the national vaccine schedule in Spain
UL https://suche.suub.uni-bremen.de/peid=base-ftunivgranada:oai:digibug.ugr.es:10481_63280&Exemplar=1&LAN=DE A1 Epstein, David Mark A1 Ruiz Montero, Rafael A1 Espín Balbino, Jaime PB Elsevier YR 2019 K1 Análisis de costo-beneficio K1 España K1 Lactantes K1 Vacunas meningocócicas K1 Preescolares K1 Neisseria meningitidis serogrupo B K1 Vacunación masiva K1 Cost benefit analysis K1 Spain K1 Infant K1 Meningococcal vaccines K1 Child K1 Preschool K1 Neisseria meningitidis serogroup B K1 Mass vaccination JF Ruiz-Montero, R., Epstein, D., Herrador, B. G., & Balbino, J. E. (2020). Evaluación económica de la inclusión en el calendario vacunal de 4CMenB (Bexsero®) en España. Gaceta Sanitaria, 34(4), 318-325. [https://doi.org/10.1016/j.gaceta.2019.08.007] LK http://hdl.handle.net/10481/63280 DO http://hdl.handle.net/10481/63280 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)